← The Wire
TRVINasdaq
Trevi Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1563880
Develops and commercializes Haduvio for chronic cough in adults with lung diseases
$2.02B
Market cap
$18.63
Last close
+2.6%
1D
+5.2%
5D
2.9M
Volume
Price · last 39 sessions+29.6%
May 4L $13.24 · H $18.63Jun 29
152
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 21, 2026DEFA14ADEFA14AApr 29, 2025DEFA14ADEFA14AApr 26, 2024DEFA14ADEFA14AMay 1, 2023DEFA14ADEFA14AMay 2, 2022DEFA14ADEFA14AApr 27, 2021DEFA14ADEFA14AMay 29, 2020DEFA14ADEFA14AApr 29, 2020
Similar companies
Comparable business profile · signals at a glance